A team of University of California, San Diego researchers has made new discoveries about a copper-transporting protein in the membranes of human cells that drug-discovery scientists can co-opt for the development of new anti-cancer drugs…. Read the full story from the UCSD Newsroom
Stephen B. Howell, MD, was on the research team, which was led by Igor Tsigelny of the Department of Neurosciences and the San Diego Supercomputer Center. Dr. Howell is professor of medicine in the Division of Hematology-Oncology and a translational researcher at the UC San Diego Moores Cancer Center, where he is associate director for clinical research.
He also directs the Cancer Therapeutics Training Program (CT2) and co-leads, with Dr. David Cheresh, the Tumor Growth, Invasion and Metastasis Program.Read the study report in Cell Biochemistry and Biophysics